HIGHLIGHTS
- who: Sammeli Liikkanen and collaborators from the Orion Corporation, Orion Pharma, RandD, Espoo Finland, DRDP, Institute of Biomedicine, University of have published the paper: Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinsonu2019s disease, in the Journal: (JOURNAL)
- what: The analysis reveals differential April 7 2023 1 / 18 __NEWPAGE__PLOS DIGITAL HEALTH Funding: This study was funded by Orion Corporation Orion Pharma Finland and Healthware Group Italy. The authors explored whether use of a commercially available wearable device together with a mobile application allows . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.